Follow Us: social media social media social media        

Pomalyst® (pomalidomide): New important advice- Hepatitis B Virus status to be established before initiating treatment with pomalidomide

Date: 19 January 2017

 

Description:

Reactivation of hepatitis B has been reported rarely following treatment with pomalidomide plus dexamethasone in patients previously infected with the hepatitis B virus (HBV). HBV status should be established before treatment with pomalidomide is initiated. A Direct Healthcare Professional Communication (DHPC) has been issued by Celgene Sdn. Bhd. in agreement with NPRA to highlight this information. Please refer to this DHPC for further information.

qrcode